Goldman Sachs’s Skye Bioscience SKYE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$309K	Buy	73,834 +30,343	+70%	+$127K	﹤0.01%	4511
2025 Q1	$69.2K	Sell	43,491 -27,588	-39%	-$43.9K	﹤0.01%	4875
2024 Q4	$201K	Buy	71,079 +23,279	+49%	+$65.9K	﹤0.01%	4666
2024 Q3	$187K	Buy	+47,800	New	+$187K	﹤0.01%	4511